Cyclo Therapeutics Files 8-K on Shareholder Votes
| Field | Detail |
|---|---|
| Company | Cyclo Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, shareholder-vote
TL;DR
Cyclo Therapeutics filed an 8-K on shareholder votes, standard corporate update.
AI Summary
Cyclo Therapeutics, Inc. filed an 8-K on March 24, 2025, reporting on matters submitted to a vote of security holders as of March 20, 2025. The filing details the company's corporate structure, including its state of incorporation (Nevada) and fiscal year end (December 31). It also lists former company names and dates of name changes, indicating a history of corporate evolution.
Why It Matters
This filing provides transparency regarding corporate governance and decisions made by Cyclo Therapeutics, Inc. that require shareholder approval.
Risk Assessment
Risk Level: low — This is a routine corporate filing detailing a vote of security holders and does not appear to contain significant new financial or operational information.
Key Players & Entities
- Cyclo Therapeutics, Inc. (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
- March 20, 2025 (date) — Date of earliest event reported
- March 24, 2025 (date) — Date of report
- CTD HOLDINGS INC (company) — Former company name
- CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC (company) — Former company name
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders as of March 20, 2025, but the specific details of these matters are not provided in the excerpt.
When was the report filed with the SEC?
The report was filed as of March 24, 2025.
In which state was Cyclo Therapeutics, Inc. incorporated?
Cyclo Therapeutics, Inc. was incorporated in Nevada.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What were some of the company's previous names?
The company was formerly known as CTD HOLDINGS INC and CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 24, 2025 regarding Cyclo Therapeutics, Inc..